Use of the mucoregulator ascoril for respiratory diseases

Abstract

The paper deals with the use of the combined mucoregulatory drug ascoril in pulmonological care. Due to its multicomponent composition, the drug has mucoregulatory properties that combine a bronchodilator effect and an ability to dilute sputum and to synthesize the surfactant. The mechanism of action of each ascoril component is analyzed; the results of basic experimental and clinical studies on the use of the drug are given. A wide range of indications, such as respiratory system diseases, for ascoril use is demonstrated.

Keywords

• salbutamol sulfate
• bromhexine hydrochloride
• guaifenisin
• chronic obstructive pulmonary disease
• asthma
• mucostasis
• mucoregulatory therapy
• respiratory system diseases